Vascular Closure Device Market is registering a substantial CAGR of 7.79% in the forecast period of 2019-2026
Vascular Closure Devices Market Research Report, by Product Type (Passive Vascular Closure Device, Active Vascular Closure Device, External Hemostatic Device), Access (Femoral, Radial), Procedures (Interventional Cardiology, Interventional Radiology), Application (Diagnostic, Therapeutic), End User (Hospitals & Clinics, ASCs) – Global Forecast Till 2023The report presents a detailed analysis of Vascular Closure Devices Market by providing readers with a comprehensive overview of the market’s historical trajectory.
The leading drivers and restraints affecting the global prostate cancer market are assessed in detail in the report.
The historical impact of these drivers and restraints is analyzed in context of the current impact of these factors and projections are made for the likely impact of these drivers and restraints over the forecast period.Major Key PlayersTo gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch.Abbott Laboratories, Terumo Corporation, Cardinal Health Inc., Cardiva Medical Inc., Morris Innovative, Inc., Medtronic plc, Essential Medical, Inc., Merit Medical Systems, Inc., TZ Medical, Inc., Vasorum Ltd., Transluminal Technologies LLC, Vascular Closure Systems, Inc., Vivasure Medical Ltd., among others.Market Segment AnalysisPlug-Based DevicesSealant or Gel-Based DevicesCompression Assist DevicesActive Vascular Closure DevicesClip-Based DevicesSuture-Based DevicesGamma-Retroviral VectorsExternal Hemostatic DevicesGlobal Vascular Closure Devices Market, by AccessFemoral AccessRadial AccessGlobal Vascular Closure Devices Market, by ProceduresInterventional cardiologyInterventional radiology/vascular surgeryGlobal Vascular Closure Devices Market, by ApplicationDiagnostic InterventionTherapeutic InterventionVascular Closure Devices Market report offers insights into the leading market players and presents an assessment of their current market position.
Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M activities, and the latest R initiatives is also available in the reportRegional AnalysisGeographically, the global Vascular Closure Devices Market has been divided by Regions/Countries, this report coversUnited StatesEuropeChinaJapanSoutheast AsiaIndiaCentral & South AmericaBrowse Full Report Page Enabled with complete Table of Content at https://www.marketresearchfuture.com/reports/vascular-closure-devices-market-5704Chapters for This Vascular Closure Devices Market Study: -Chapter 1: to describe Global Vascular Closure Devices Market Introduction, product scope, market overview, market opportunities, market risk, market driving force;Chapter 2: to analyze the top manufacturers of Global Vascular Closure Devices Market, with sales, revenue, and price of Global Vascular Closure Devices Market.Chapter 3: to display the competitive situation among the top manufacturers, with sales, revenue and market share in Forecasted Time.Chapter 4: to show the Global Vascular Closure Devices Market by regions, with sales, revenue and market share of Global Vascular Closure Devices Market, for each region, during the forecast period.Chapter 5, 6, 7, 8 and 9: to analyze the key regions, with sales, revenue and market share by key countries in these regions;Chapter 10: to show the market by type and application, with sales market share and growth rate by type, application, Methodology, Analyst Introduction, Data Source By MRFRAbout Market Research Future: MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.Contact:+1 646 845 9312 | Email: [email protected]
Market ScenarioGlobal Vascular Closure Devices Market was valued US$ 705 Mn in 2017 and is expected to reach US$ 1286.5 Mn by 2026, at a CAGR of 7.81 % during a forecast period.The vascular closure devices market is segmented into product, end user, access, hole size, and region.In terms of product, vascular closure devices market is segmented into passive approximators and active approximators.
Based on end user segment, vascular closure devices market is classified into interventional cardiology, interventional radiology & vascular surgery.
Based on regions, the global vascular closure devices market is divided into five main regions are North America, Europe, Asia-pacific, Latin America and Middle East & Africa.For more info, Get PDF at: https://www.trendsmarketresearch.com/report/sample/11285Global Vascular Closure Devices MarketVascular closure devices are used to achieve hemostasis after a cardiovascular procedure.
In terms of product, Active approximators dominated the VCD industry owing to high-efficiency rate and presence of broad product portfolio in this segment.
Passive approximators are the fastest growing segment as they provide reliable and quick hemostasis of vascular access site.On the basis of the end user, the interventional cardiology segment is expected to dominate the market due to the high prevalence of cardiovascular diseases and the rapidly increasing heavy population.Based on access, the femoral access segment is estimated to account for the largest share of the market owing to an increasing number of cardiologists and physicians opting for femoral access in interventional procedures, the market is expected to witness significant growth during the forecast period.High prevalence of cardiovascular diseases, high incidence of obesity and a rising need for minimally invasive procedures are boosting the global vascular closure devices market growth.
Additionally, increasing healthcare expenditure and demand for new treatment options along with the rise in government support are expected to drive the growth of the market.The increasing interventional procedures using radial access, the high cost of vascular closure devices, and the risks associated with vascular closure devices are the major restraints for the market.You can Buy This Report from Here @ https://www.trendsmarketresearch.com/checkout/11285/SingleNeed for highly skilled professionals is the major challenge for the global vascular closure devices market.
The Left Atrial Appendage Closure Device Market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.
This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the left atrial appendage closure device market include Boston Scientific Corporation, AtriCure, St. Jude Medical, Lifetech Scientific (Shenzhen), Coherex Medical.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Left Atrial Appendage Closure Device Market Research Report" by requesting FREE Sample Copy athttps://www.valuemarketresearch.com/contact/left-atrial-appendage-closure-device-market/download-sampleMarket DynamicsStroke is a serious risk for patients with atrial fibrillation.
Atrial fibrillation (AFib) is the most widely recognized heart rhythm abnormality, affecting more than 33 million individuals around the world.
Also, Surge in government initiatives to raise public awareness related to cardiovascular diseases and attractive health insurance policies are likely to influence the growth of left atrial appendage closure device market.
Upmarketresearch offers a latest published report on “global Vascular Closure Devices market analysis and forecast 2018-2023” delivering key insights and providing a competitive advantage to clients through a detailed report.
The report contains 108 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.Get exclusive free pdf sample copy of this report @https://www.upmarketresearch.com/home/requested_sample/6872Vascular Closure Devices industry research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.
Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
The numerical data is backed up by statistical tools such as swot analysis, bcg matrix, scot analysis, pestle analysis and so on.
The statistics are represented in graphical format for a clear understanding on facts and figures.The generated report is firmly based on primary research, interviews with top executives, news sources and information insiders.
Secondary research techniques are implemented for better understanding and clarity for data analysis.The report for Vascular Closure Devices market analysis & forecast 2018-2023 is segmented into product segment, application segment & major players.Region-wise analysis global Vascular Closure Devices market covers: North america Europe China Japan India Southeast asia Other regions (central & south america, middle east & africa)The major players reported in the market include:Abbott LaboratoriesCardinal HealthSt.
PDA Device Closure procedure in India.
The ductus arteriosus is present in all foetuses enabling blood to bypass the non-working lungs.
During childbirth or not long after birth as the infant inhales, the Ductus Arteriosus would usually close permanently.
Inability to do so outcomes in Patent Ductus Arteriosus (PDA) which is an open channel enabling blood to flow out of the aorta (vein carrying blood from the heart to the entire body) to the pulmonary artery (vein supplying the lung).
Vascular Closure Devices Market Analysis The vascular closure devices market is predicted to grow at a 6.8% CAGR over the forecast period (2018-2023), states the new Market Research Future (MRFR) report.
Besides, it also helps in reducing time to hospital discharge and time to ambulation.
Some of the drivers according to the Market Research Future (MRFR) the vascular closure device market report, include rising prevalence of various neurovascular and cardiovascular diseases, growing adoption of minimally invasive techniques, increasing investments by government organizations, and untapped market opportunities especially in emerging countries.
Based on access, the global vascular closure devices market is segmented into radial access and femoral access.
Based on end user, the vascular closure devices market is segmented into ambulatory surgery centers, specialty centers, hospitals and clinics, and others.
Vascular Closure Devices Market Regional Analysis Based on the region, the global vascular closure devices market report covers the latest trends and growth opportunities across the Americas, Europe, the Asia Pacific, and the Middle East and Africa.
11 February 2020 - The global Peripheral Vascular Device Market size was estimated at USD 5,888.5 million in 2014 and is expected to grow at a CAGR of 7.2% over the forecast period.
According to an estimate of Central Disease for Control and Prevention, about 8.5 million people in the U.S have peripheral artery disease including 12-20% of individuals ageing 60 years and above.
Rising chronic conditions including diabetes, obesity and end-stage renal disease is one of the crucial factors anticipated to boost demand for these devices.
However, the market growth is expected to negatively impact the market owing to factors such as reimbursement issues in developing countries, stringent regulatory policies, and presence of highly fragmented market.
Product Insights Based on the products, the market is segmented as peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, embolic protection devices, and inferior vena cava filters.
Peripheral angioplasty balloon catheters held significant market share owing to introduction of technological advance products like drug coated balloons and favorable reimbursement policies in developed countries like Germany and the U.S.
Central venous/vascular access devices are small, flexible tubes placed in large veins for people who require frequent access to the bloodstream.
Venous access devices that can be implanted under the skin were introduced in 1982.
They allow medications to be delivered directly into larger veins, are less likely to clot, and can be left in for long periods.
The CVAD may contain one or two tubes.
When a CVAD contains two tubes, it is called a double or dual lumen catheter and may also be used for injecting contrast for CT or MRI scans (depending on type of CVAD).In terms of percentage share contribution by product, the peripheral catheters segment is expected to account for 48.24% by 2025, emerging as the leading segment by value.The central vascular access devices market is largely consolidated, with the top five players accounting for a share of over 69% in 2017.
Bard, Teleflex, Inc., Terumo Corporation, Smiths Medical, Inc and Edwards Lifesciences Corporation are leading the market, other prominent players include Becton Dickinson, B.Braun, Vygon Ltd, AngioDynamics.Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-central-vascular-access-device-2019-2024-767According to this study, over the next five years the Central Vascular Access Device market will register a 5.5% CAGR in terms of revenue, the global market size will reach US$ 2410 million by 2024, from US$ 1850 million in 2019.
Left Atrial Appendage Closure Device Market report published by Value Market Research, which studies the future outlook of the market.
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the left atrial appendage closure device market include Boston Scientific Corporation, AtriCure, St. Jude Medical, Lifetech Scientific (Shenzhen), Coherex Medical.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Left Atrial Appendage Closure Device Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/left-atrial-appendage-closure-device-market/download-sampleMarket DynamicsStroke is a serious risk for patients with atrial fibrillation.
Atrial fibrillation (AFib) is the most widely recognized heart rhythm abnormality, affecting more than 33 million individuals around the world.
Also, Surge in government initiatives to raise public awareness related to cardiovascular diseases and attractive health insurance policies are likely to influence the growth of left atrial appendage closure device market.
Vascular Closure Devices Market Research Report, by Product Type (Passive Vascular Closure Device, Active Vascular Closure Device, External Hemostatic Device), Access (Femoral, Radial), Procedures (Interventional Cardiology, Interventional Radiology), Application (Diagnostic, Therapeutic), End User (Hospitals & Clinics, ASCs) – Global Forecast Till 2023The report presents a detailed analysis of Vascular Closure Devices Market by providing readers with a comprehensive overview of the market’s historical trajectory.
The leading drivers and restraints affecting the global prostate cancer market are assessed in detail in the report.
The historical impact of these drivers and restraints is analyzed in context of the current impact of these factors and projections are made for the likely impact of these drivers and restraints over the forecast period.Major Key PlayersTo gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch.Abbott Laboratories, Terumo Corporation, Cardinal Health Inc., Cardiva Medical Inc., Morris Innovative, Inc., Medtronic plc, Essential Medical, Inc., Merit Medical Systems, Inc., TZ Medical, Inc., Vasorum Ltd., Transluminal Technologies LLC, Vascular Closure Systems, Inc., Vivasure Medical Ltd., among others.Market Segment AnalysisPlug-Based DevicesSealant or Gel-Based DevicesCompression Assist DevicesActive Vascular Closure DevicesClip-Based DevicesSuture-Based DevicesGamma-Retroviral VectorsExternal Hemostatic DevicesGlobal Vascular Closure Devices Market, by AccessFemoral AccessRadial AccessGlobal Vascular Closure Devices Market, by ProceduresInterventional cardiologyInterventional radiology/vascular surgeryGlobal Vascular Closure Devices Market, by ApplicationDiagnostic InterventionTherapeutic InterventionVascular Closure Devices Market report offers insights into the leading market players and presents an assessment of their current market position.
Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M activities, and the latest R initiatives is also available in the reportRegional AnalysisGeographically, the global Vascular Closure Devices Market has been divided by Regions/Countries, this report coversUnited StatesEuropeChinaJapanSoutheast AsiaIndiaCentral & South AmericaBrowse Full Report Page Enabled with complete Table of Content at https://www.marketresearchfuture.com/reports/vascular-closure-devices-market-5704Chapters for This Vascular Closure Devices Market Study: -Chapter 1: to describe Global Vascular Closure Devices Market Introduction, product scope, market overview, market opportunities, market risk, market driving force;Chapter 2: to analyze the top manufacturers of Global Vascular Closure Devices Market, with sales, revenue, and price of Global Vascular Closure Devices Market.Chapter 3: to display the competitive situation among the top manufacturers, with sales, revenue and market share in Forecasted Time.Chapter 4: to show the Global Vascular Closure Devices Market by regions, with sales, revenue and market share of Global Vascular Closure Devices Market, for each region, during the forecast period.Chapter 5, 6, 7, 8 and 9: to analyze the key regions, with sales, revenue and market share by key countries in these regions;Chapter 10: to show the market by type and application, with sales market share and growth rate by type, application, Methodology, Analyst Introduction, Data Source By MRFRAbout Market Research Future: MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.Contact:+1 646 845 9312 | Email: [email protected]
Vascular Closure Devices Market Analysis The vascular closure devices market is predicted to grow at a 6.8% CAGR over the forecast period (2018-2023), states the new Market Research Future (MRFR) report.
Besides, it also helps in reducing time to hospital discharge and time to ambulation.
Some of the drivers according to the Market Research Future (MRFR) the vascular closure device market report, include rising prevalence of various neurovascular and cardiovascular diseases, growing adoption of minimally invasive techniques, increasing investments by government organizations, and untapped market opportunities especially in emerging countries.
Based on access, the global vascular closure devices market is segmented into radial access and femoral access.
Based on end user, the vascular closure devices market is segmented into ambulatory surgery centers, specialty centers, hospitals and clinics, and others.
Vascular Closure Devices Market Regional Analysis Based on the region, the global vascular closure devices market report covers the latest trends and growth opportunities across the Americas, Europe, the Asia Pacific, and the Middle East and Africa.
Market ScenarioGlobal Vascular Closure Devices Market was valued US$ 705 Mn in 2017 and is expected to reach US$ 1286.5 Mn by 2026, at a CAGR of 7.81 % during a forecast period.The vascular closure devices market is segmented into product, end user, access, hole size, and region.In terms of product, vascular closure devices market is segmented into passive approximators and active approximators.
Based on end user segment, vascular closure devices market is classified into interventional cardiology, interventional radiology & vascular surgery.
Based on regions, the global vascular closure devices market is divided into five main regions are North America, Europe, Asia-pacific, Latin America and Middle East & Africa.For more info, Get PDF at: https://www.trendsmarketresearch.com/report/sample/11285Global Vascular Closure Devices MarketVascular closure devices are used to achieve hemostasis after a cardiovascular procedure.
In terms of product, Active approximators dominated the VCD industry owing to high-efficiency rate and presence of broad product portfolio in this segment.
Passive approximators are the fastest growing segment as they provide reliable and quick hemostasis of vascular access site.On the basis of the end user, the interventional cardiology segment is expected to dominate the market due to the high prevalence of cardiovascular diseases and the rapidly increasing heavy population.Based on access, the femoral access segment is estimated to account for the largest share of the market owing to an increasing number of cardiologists and physicians opting for femoral access in interventional procedures, the market is expected to witness significant growth during the forecast period.High prevalence of cardiovascular diseases, high incidence of obesity and a rising need for minimally invasive procedures are boosting the global vascular closure devices market growth.
Additionally, increasing healthcare expenditure and demand for new treatment options along with the rise in government support are expected to drive the growth of the market.The increasing interventional procedures using radial access, the high cost of vascular closure devices, and the risks associated with vascular closure devices are the major restraints for the market.You can Buy This Report from Here @ https://www.trendsmarketresearch.com/checkout/11285/SingleNeed for highly skilled professionals is the major challenge for the global vascular closure devices market.
11 February 2020 - The global Peripheral Vascular Device Market size was estimated at USD 5,888.5 million in 2014 and is expected to grow at a CAGR of 7.2% over the forecast period.
According to an estimate of Central Disease for Control and Prevention, about 8.5 million people in the U.S have peripheral artery disease including 12-20% of individuals ageing 60 years and above.
Rising chronic conditions including diabetes, obesity and end-stage renal disease is one of the crucial factors anticipated to boost demand for these devices.
However, the market growth is expected to negatively impact the market owing to factors such as reimbursement issues in developing countries, stringent regulatory policies, and presence of highly fragmented market.
Product Insights Based on the products, the market is segmented as peripheral vascular stents, peripheral transluminal angioplasty balloon catheters, PTA guidewires, atherectomy devices, chronic total occlusion devices, aortic stents, synthetic surgical grafts, embolic protection devices, and inferior vena cava filters.
Peripheral angioplasty balloon catheters held significant market share owing to introduction of technological advance products like drug coated balloons and favorable reimbursement policies in developed countries like Germany and the U.S.
The Left Atrial Appendage Closure Device Market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.
This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the left atrial appendage closure device market include Boston Scientific Corporation, AtriCure, St. Jude Medical, Lifetech Scientific (Shenzhen), Coherex Medical.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Left Atrial Appendage Closure Device Market Research Report" by requesting FREE Sample Copy athttps://www.valuemarketresearch.com/contact/left-atrial-appendage-closure-device-market/download-sampleMarket DynamicsStroke is a serious risk for patients with atrial fibrillation.
Atrial fibrillation (AFib) is the most widely recognized heart rhythm abnormality, affecting more than 33 million individuals around the world.
Also, Surge in government initiatives to raise public awareness related to cardiovascular diseases and attractive health insurance policies are likely to influence the growth of left atrial appendage closure device market.
Upmarketresearch offers a latest published report on “global Vascular Closure Devices market analysis and forecast 2018-2023” delivering key insights and providing a competitive advantage to clients through a detailed report.
The report contains 108 pages which highly exhibit on current market analysis scenario, upcoming as well as future opportunities, revenue growth, pricing and profitability.Get exclusive free pdf sample copy of this report @https://www.upmarketresearch.com/home/requested_sample/6872Vascular Closure Devices industry research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.
Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
The numerical data is backed up by statistical tools such as swot analysis, bcg matrix, scot analysis, pestle analysis and so on.
The statistics are represented in graphical format for a clear understanding on facts and figures.The generated report is firmly based on primary research, interviews with top executives, news sources and information insiders.
Secondary research techniques are implemented for better understanding and clarity for data analysis.The report for Vascular Closure Devices market analysis & forecast 2018-2023 is segmented into product segment, application segment & major players.Region-wise analysis global Vascular Closure Devices market covers: North america Europe China Japan India Southeast asia Other regions (central & south america, middle east & africa)The major players reported in the market include:Abbott LaboratoriesCardinal HealthSt.
Central venous/vascular access devices are small, flexible tubes placed in large veins for people who require frequent access to the bloodstream.
Venous access devices that can be implanted under the skin were introduced in 1982.
They allow medications to be delivered directly into larger veins, are less likely to clot, and can be left in for long periods.
The CVAD may contain one or two tubes.
When a CVAD contains two tubes, it is called a double or dual lumen catheter and may also be used for injecting contrast for CT or MRI scans (depending on type of CVAD).In terms of percentage share contribution by product, the peripheral catheters segment is expected to account for 48.24% by 2025, emerging as the leading segment by value.The central vascular access devices market is largely consolidated, with the top five players accounting for a share of over 69% in 2017.
Bard, Teleflex, Inc., Terumo Corporation, Smiths Medical, Inc and Edwards Lifesciences Corporation are leading the market, other prominent players include Becton Dickinson, B.Braun, Vygon Ltd, AngioDynamics.Download FREE Sample of this Report @ https://www.grandresearchstore.com/report-sample/global-central-vascular-access-device-2019-2024-767According to this study, over the next five years the Central Vascular Access Device market will register a 5.5% CAGR in terms of revenue, the global market size will reach US$ 2410 million by 2024, from US$ 1850 million in 2019.
Left Atrial Appendage Closure Device Market report published by Value Market Research, which studies the future outlook of the market.
It includes the size, share, growth, trends, key players, segments and regional analysis in detail during the study year 2020-2027.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the left atrial appendage closure device market include Boston Scientific Corporation, AtriCure, St. Jude Medical, Lifetech Scientific (Shenzhen), Coherex Medical.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Left Atrial Appendage Closure Device Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/left-atrial-appendage-closure-device-market/download-sampleMarket DynamicsStroke is a serious risk for patients with atrial fibrillation.
Atrial fibrillation (AFib) is the most widely recognized heart rhythm abnormality, affecting more than 33 million individuals around the world.
Also, Surge in government initiatives to raise public awareness related to cardiovascular diseases and attractive health insurance policies are likely to influence the growth of left atrial appendage closure device market.
PDA Device Closure procedure in India.
The ductus arteriosus is present in all foetuses enabling blood to bypass the non-working lungs.
During childbirth or not long after birth as the infant inhales, the Ductus Arteriosus would usually close permanently.
Inability to do so outcomes in Patent Ductus Arteriosus (PDA) which is an open channel enabling blood to flow out of the aorta (vein carrying blood from the heart to the entire body) to the pulmonary artery (vein supplying the lung).